Untreated Adult Acute Myeloid Leukemia Recruiting Phase 2 Trials for Cytarabine (DB00987)

DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03629171Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid LeukemiaTreatment
NCT02835222Selinexor With Induction, Consolidation, and Maintenance Therapy in Treating Older Patients With Acute Myeloid LeukemiaTreatment
NCT02583893Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid LeukemiaBasic Science
NCT00801489Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeTreatment